In a multicenter , randomized , parallel-group trial , 2021 patients 70 years of age or older who were undergoing their first pacemaker implant for high-grade atrioventricular block were randomly assigned to receive a single-chamber ventricular pacemaker ( 1009 patients ) or a dual-chamber pacemaker ( 1012 patients ) .
